Cargando…
Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged at the end of 2019, causing the coronavirus disease (COVID-19). The main sources of infections are infected and asymptomatic persons. One major problem of the pandemic are the diverse symptoms and the varying manifestations o...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496944/ http://dx.doi.org/10.1016/j.clicom.2021.08.002 |
_version_ | 1784579857365073920 |
---|---|
author | Mara, Elisabeth Breitsching, Verena Schuster, Tanja Pekar, Thomas |
author_facet | Mara, Elisabeth Breitsching, Verena Schuster, Tanja Pekar, Thomas |
author_sort | Mara, Elisabeth |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged at the end of 2019, causing the coronavirus disease (COVID-19). The main sources of infections are infected and asymptomatic persons. One major problem of the pandemic are the diverse symptoms and the varying manifestations of the illness. In this study, the IgG level recognizing the RBD of SARS-CoV-2 was determined within 336 volunteers from the environment of the University of Applied Sciences Wiener Neustadt. The aims of this study were to identify the estimated number of undiscovered COVID-19 infections and the corresponding antibody levels. In total, 11.3% of the nonvaccinated probands had a positive IgG antibody titer against SARS-CoV-2, whereas 4.0% did not test positive for SARS-CoV-2 or had never been tested at the time of sampling. Probands in this study reported tiredness (57,5%), ageusia/anosmia (55%) and headache (47,5%) as most frequent symptoms. |
format | Online Article Text |
id | pubmed-8496944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84969442021-10-08 Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort Mara, Elisabeth Breitsching, Verena Schuster, Tanja Pekar, Thomas Clinical Immunology Communications Short Communication Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged at the end of 2019, causing the coronavirus disease (COVID-19). The main sources of infections are infected and asymptomatic persons. One major problem of the pandemic are the diverse symptoms and the varying manifestations of the illness. In this study, the IgG level recognizing the RBD of SARS-CoV-2 was determined within 336 volunteers from the environment of the University of Applied Sciences Wiener Neustadt. The aims of this study were to identify the estimated number of undiscovered COVID-19 infections and the corresponding antibody levels. In total, 11.3% of the nonvaccinated probands had a positive IgG antibody titer against SARS-CoV-2, whereas 4.0% did not test positive for SARS-CoV-2 or had never been tested at the time of sampling. Probands in this study reported tiredness (57,5%), ageusia/anosmia (55%) and headache (47,5%) as most frequent symptoms. The Authors. Published by Elsevier Inc. 2021-12 2021-10-07 /pmc/articles/PMC8496944/ http://dx.doi.org/10.1016/j.clicom.2021.08.002 Text en © 2021 The Authors. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Mara, Elisabeth Breitsching, Verena Schuster, Tanja Pekar, Thomas Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort |
title | Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort |
title_full | Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort |
title_fullStr | Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort |
title_full_unstemmed | Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort |
title_short | Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort |
title_sort | prevalence of asymptomatic sars-cov-2 infection in an austrian cohort |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496944/ http://dx.doi.org/10.1016/j.clicom.2021.08.002 |
work_keys_str_mv | AT maraelisabeth prevalenceofasymptomaticsarscov2infectioninanaustriancohort AT breitschingverena prevalenceofasymptomaticsarscov2infectioninanaustriancohort AT schustertanja prevalenceofasymptomaticsarscov2infectioninanaustriancohort AT pekarthomas prevalenceofasymptomaticsarscov2infectioninanaustriancohort |